AVTX·05338F306·US·equity·Healthcare - Biotechnology-13D/G
AVTX (AVALO THERAPEUTICS INC) is held by 50 institutional investors as of Q1 2026. Largest holders: FMR LLC ($43M), Avoro Capital Advisors LLC ($21.1M), UBS Group AG ($17M). Net institutional sentiment: Mixed.
See how AVTX's score breaks down across 4 SEC sources
Showing 1-20 of 59
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer